NO20053116D0 - Fettregulering. - Google Patents
Fettregulering.Info
- Publication number
- NO20053116D0 NO20053116D0 NO20053116A NO20053116A NO20053116D0 NO 20053116 D0 NO20053116 D0 NO 20053116D0 NO 20053116 A NO20053116 A NO 20053116A NO 20053116 A NO20053116 A NO 20053116A NO 20053116 D0 NO20053116 D0 NO 20053116D0
- Authority
- NO
- Norway
- Prior art keywords
- fats
- regulation
- fats regulation
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Hematology (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Obesity (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Diabetes (AREA)
- Molecular Biology (AREA)
- Child & Adolescent Psychology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Plant Substances (AREA)
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US43135102P | 2002-12-06 | 2002-12-06 | |
US47633103P | 2003-06-06 | 2003-06-06 | |
US47672603P | 2003-06-06 | 2003-06-06 | |
US10/729,167 US7618940B2 (en) | 2002-12-06 | 2003-12-04 | Fat regulation |
PCT/US2003/038690 WO2004052285A2 (en) | 2002-12-06 | 2003-12-05 | Fat regulation |
Publications (2)
Publication Number | Publication Date |
---|---|
NO20053116D0 true NO20053116D0 (no) | 2005-06-24 |
NO20053116L NO20053116L (no) | 2005-09-05 |
Family
ID=32512564
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20053116A NO20053116L (no) | 2002-12-06 | 2005-06-24 | Fettregulering. |
Country Status (9)
Country | Link |
---|---|
US (2) | US7618940B2 (no) |
EP (1) | EP1578431A4 (no) |
JP (1) | JP2006514113A (no) |
AU (1) | AU2003298926C1 (no) |
CA (1) | CA2506159C (no) |
HK (1) | HK1087338A1 (no) |
IL (1) | IL168323A (no) |
NO (1) | NO20053116L (no) |
WO (1) | WO2004052285A2 (no) |
Families Citing this family (48)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7618940B2 (en) | 2002-12-06 | 2009-11-17 | Fibrogen, Inc. | Fat regulation |
US8124582B2 (en) * | 2002-12-06 | 2012-02-28 | Fibrogen, Inc. | Treatment of diabetes |
US8614204B2 (en) | 2003-06-06 | 2013-12-24 | Fibrogen, Inc. | Enhanced erythropoiesis and iron metabolism |
CN102977015B (zh) | 2003-06-06 | 2015-05-06 | 菲布罗根有限公司 | 含氮杂芳基化合物及其在增加内源性促红细胞生成素中的用途 |
CN103382216B (zh) * | 2006-01-27 | 2016-04-20 | 菲布罗根有限公司 | 使低氧诱导因子(hif)稳定的氰基异喹啉化合物 |
US7625927B2 (en) * | 2006-02-27 | 2009-12-01 | Alcon Research, Ltd. | Method of treating glaucoma |
US7745461B1 (en) | 2006-02-27 | 2010-06-29 | Alcon Research, Ltd. | Method of treating dry eye disorders |
CA2647596C (en) * | 2006-04-04 | 2012-06-12 | Fibrogen, Inc. | Pyrrolo- and thiazolo-pyridine compounds as hif modulators |
US20080050740A1 (en) * | 2006-06-23 | 2008-02-28 | Cassidy Pamela M | Nutritional and Exercise Plan Based On A Person's Individual Genetic APO E Genotype |
ES2705587T3 (es) | 2006-06-26 | 2019-03-26 | Akebia Therapeutics Inc | Inhibidores de prolil hidroxilasa y métodos de uso |
AU2007334321B2 (en) * | 2006-12-18 | 2012-03-08 | Amgen Inc. | Azaquinolone based compounds exhibiting prolyl hydroxylase inhibitory activity, compositions, and uses thereof |
US7635715B2 (en) * | 2006-12-18 | 2009-12-22 | Amgen Inc. | Naphthalenone compounds exhibiting prolyl hydroxylase inhibitory activity, compositions, and uses thereof |
AU2008241483B2 (en) * | 2007-04-18 | 2011-03-24 | Amgen Inc. | Quinolones and azaquinolones that inhibit prolyl hydroxylase |
EP2155680B1 (en) * | 2007-04-18 | 2013-12-04 | Amgen, Inc | Indanone derivatives that inhibit prolyl hydroxylase |
WO2008137084A2 (en) * | 2007-05-04 | 2008-11-13 | Amgen Inc. | Diazaquinolones that inhibit prolyl hydroxylase activity |
US8030346B2 (en) * | 2007-05-04 | 2011-10-04 | Amgen Inc. | Heterocyclic quinolone derivatives that inhibit prolyl hydroxylase activity |
WO2009073669A1 (en) * | 2007-12-03 | 2009-06-11 | Fibrogen, Inc. | Isoxazolopyridine derivatives for use in the treatment of hif-mediated conditions |
US8952160B2 (en) * | 2008-01-11 | 2015-02-10 | Fibrogen, Inc. | Isothiazole-pyridine derivatives as modulators of HIF (hypoxia inducible factor) activity |
US8324405B2 (en) | 2008-02-05 | 2012-12-04 | Fibrogen, Inc. | Chromene derivatives and use thereof as HIF hydroxylase activity inhibitors |
WO2009134754A1 (en) | 2008-04-28 | 2009-11-05 | Janssen Pharmaceutica Nv | Benzoimidazole glycinamides as prolyl hydroxylase inhibitors |
EP2334682B1 (en) * | 2008-08-20 | 2017-10-04 | Fibrogen, Inc. | Pyrrolo [ 1, 2 -b] pyridazine derivatives and their use as hif modulators |
WO2010056767A1 (en) | 2008-11-14 | 2010-05-20 | Fibrogen, Inc. | Thiochromene derivatives as hip hydroxylase inhibitors |
JP5643233B2 (ja) | 2009-02-10 | 2014-12-17 | ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプJanssen Pharmaceutica Naamloze Vennootschap | プロリルヒドロキシラーゼ阻害物質としてのキナゾリノン |
US8796263B2 (en) | 2010-08-13 | 2014-08-05 | Janssen Pharmaceutica Nv | 4-aminoquinazolin-2-yl-1-pyrrazole-4-carboxylic acid compounds as prolyl hydroxylase inhibitors |
WO2012106472A1 (en) | 2011-02-02 | 2012-08-09 | Fibrogen, Inc. | Naphthyridine derivatives as inhibitors of hypoxia inducible factor (hif) hydroxylase |
WO2012105630A1 (ja) * | 2011-02-03 | 2012-08-09 | 国立大学法人広島大学 | 脂質代謝関連疾患の検査方法、ならびに脂質代謝関連疾患の予防および/または治療剤の評価方法 |
GB201102659D0 (en) | 2011-02-15 | 2011-03-30 | Isis Innovation | Assay |
CN103717214A (zh) | 2011-06-06 | 2014-04-09 | 阿克比治疗有限公司 | 用于稳定低氧诱导因子-2α作为治疗癌症的方法的化合物和组合物 |
NO2686520T3 (no) | 2011-06-06 | 2018-03-17 | ||
GB201113101D0 (en) | 2011-07-28 | 2011-09-14 | Isis Innovation | Assay |
MX344109B (es) | 2011-10-25 | 2016-12-05 | Janssen Pharmaceutica Nv | Formulaciones de sal de meglumina del ácido 1-(5,6-dicloro-1h-benz o[d]imidazol-2-il)-1h-pirazol-4-carboxílico. |
EP2822545A4 (en) * | 2012-03-09 | 2015-08-12 | Fibrogen Inc | TREATMENT OF HIGH RATE OF CHOLESTEROL |
EP2834220B1 (en) | 2012-03-09 | 2016-11-09 | Fibrogen, Inc. | 4-hydroxy-isoquinoline compounds as hif hydroxylase inhibitors |
US8883823B2 (en) | 2012-07-16 | 2014-11-11 | Fibrogen, Inc. | Crystalline forms of a prolyl hydroxylase inhibitor |
MY171483A (en) * | 2012-07-16 | 2019-10-15 | Fibrogen Inc | Process for making isoquinoline compounds |
CN107540607A (zh) | 2012-07-16 | 2018-01-05 | 菲布罗根有限公司 | 脯氨酰羟化酶抑制剂的晶体形态 |
RU2666144C2 (ru) | 2013-01-24 | 2018-09-06 | Фиброген, Инк. | Кристаллические формы { [1-циано-5-(4-хлорофенокси)-4-гидроксиизохинолин-3-карбонил]-амино} -уксусной кислоты |
KR20220164069A (ko) | 2013-06-06 | 2022-12-12 | 피브로겐, 인크. | Hif 하이드록실라제 억제자의 약학적 제형 |
ES2974273T3 (es) | 2013-06-13 | 2024-06-26 | Akebia Therapeutics Inc | Composiciones y métodos para tratar la anemia |
TWI665190B (zh) | 2013-11-15 | 2019-07-11 | 阿克比治療有限公司 | {[5-(3-氯苯基)-3-羥基吡啶-2-羰基]胺基}乙酸之固體型式,其組合物及用途 |
WO2016118858A1 (en) | 2015-01-23 | 2016-07-28 | Akebia Therapeutics, Inc. | Solid forms of 2-(5-(3-fluorophenyl)-3-hydroxypicolinamido)acetic acid, compositions, and uses thereof |
HUE056958T2 (hu) | 2015-04-01 | 2022-04-28 | Akebia Therapeutics Inc | Készítmények és eljárások vérszegénység kezelésére |
US20180306788A1 (en) * | 2015-04-07 | 2018-10-25 | President And Fellows Of Harvard College | Compositions and methods for modulating hydroxylation of acc2 by phd3 |
CN106083720B (zh) | 2016-02-28 | 2018-09-11 | 深圳市塔吉瑞生物医药有限公司 | 一种取代的杂芳基化合物及包含该化合物的组合物及其用途 |
CA3058352A1 (en) * | 2017-03-29 | 2018-10-04 | Eduardo Munoz Blanco | Cannabidiol derivatives as inhibitors of the hif prolyl hydroxylases activity |
US11713298B2 (en) | 2018-05-09 | 2023-08-01 | Akebia Therapeutics, Inc. | Process for preparing 2-[[5-(3-chlorophenyl)-3-hydroxypyridine-2-carbonyl]amino]acetic acid |
KR20210077693A (ko) * | 2018-10-12 | 2021-06-25 | 미라키 이노베이션 씽크 탱크 엘엘씨 | 지방 감소용 냉각 용액 |
US11524939B2 (en) | 2019-11-13 | 2022-12-13 | Akebia Therapeutics, Inc. | Solid forms of {[5-(3-chlorophenyl)-3-hydroxypyridine-2-carbonyl]amino} acetic acid |
Family Cites Families (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE878480C (de) * | 1951-05-16 | 1953-06-05 | Richard Abr Herder Fa | Drehmomentschluessel |
TW352384B (en) * | 1992-03-24 | 1999-02-11 | Hoechst Ag | Sulfonamido- or sulfonamidocarbonylpyridine-2-carboxamides, process for their preparation and their use as pharmaceuticals |
EP0650961B1 (de) | 1993-11-02 | 1997-03-05 | Hoechst Aktiengesellschaft | Substituierte heterocyclische Carbonsäureamide, ihre Herstellung und ihre Verwendung als Arzneimittel |
DK0650960T3 (da) * | 1993-11-02 | 1997-09-01 | Hoechst Ag | Substituerede heterocykliske carboxylsyreamid-estere, deres fremstilling og deres anvendelse som lægemidler. |
CA2138929A1 (en) * | 1993-12-30 | 1995-07-01 | Klaus Weidmann | Substituted heterocyclic carboxamides, their preparation and their use as pharmaceuticals |
GB9402857D0 (en) * | 1994-02-15 | 1994-04-06 | Isis Innovation | Targeting gene therapy |
DE4410423A1 (de) * | 1994-03-25 | 1995-09-28 | Hoechst Ag | Sulfonamidocarbonylpyridin-2-carbonsäureamide sowie ihre Pyridin-N-oxide, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel |
DE4410480A1 (de) * | 1994-03-25 | 1995-09-28 | Hoechst Ag | Sulfonamidocarbonylpyridin-2-carbonsäureesteramide sowie ihre Pyridin-N-oxide, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel |
IL135495A (en) * | 1995-09-28 | 2002-12-01 | Hoechst Ag | Intermediate compounds for the preparation of quinoline-converted amines - 2 - carboxylic acid |
CN1230114A (zh) * | 1996-07-12 | 1999-09-29 | 史密丝克莱恩比彻姆有限公司 | Leptine抵抗的新疗法 |
DE19650215A1 (de) * | 1996-12-04 | 1998-06-10 | Hoechst Ag | 3-Hydroxypyridin-2-carbonsäureamidester, ihre Herstellung und ihre Verwendung als Arzneimittel |
EP0878480A1 (en) * | 1997-05-14 | 1998-11-18 | H.W. Prof. Dr. Müller | A method for the improvement of neuronal regeneration |
DE19746287A1 (de) * | 1997-10-20 | 1999-04-22 | Hoechst Marion Roussel De Gmbh | Substituierte Isochinolin-2-Carbonsäureamide, ihre Herstellung und ihre Verwendung als Arzneimittel |
US5916898A (en) * | 1997-10-24 | 1999-06-29 | Zeneca Limited | Phenanthroline derivatives |
WO1999021860A1 (en) | 1997-10-24 | 1999-05-06 | Fibrogen, Inc. | Phenanthroline derivatives |
US6200974B1 (en) * | 1997-10-24 | 2001-03-13 | Zeneca Limited | Phenanthroline derivatives |
EP1034267A1 (en) * | 1997-12-04 | 2000-09-13 | Genzyme Corporation | Compositions and methods for inducing gene expression |
US6124131A (en) * | 1998-08-25 | 2000-09-26 | The Johns Hopkins University School Of Medicine | Mutant hypoxia inducible factor-1 HIF-1 |
WO2002074981A2 (en) | 2001-03-21 | 2002-09-26 | Isis Innovation Ltd. | Assays, methods and means relating to hypoxia inducible factor (hif) hydroxylase |
WO2002081751A2 (en) * | 2001-04-03 | 2002-10-17 | The Regents Of The University Of California | A method of increasing endogenous leptin production |
WO2003045440A1 (en) | 2001-11-28 | 2003-06-05 | Angiogenetics Sweden Ab | Regulation of hypoxia-inducible gene expression with antisense inhibitory pas domain protein |
US20030153503A1 (en) | 2001-12-06 | 2003-08-14 | Klaus Stephen J. | Methods of increasing endogenous erythropoietin (EPO) |
GB0206711D0 (en) | 2002-03-21 | 2002-05-01 | Isis Innovation | HIF Inhibitor |
JP2004083570A (ja) * | 2002-06-25 | 2004-03-18 | Sankyo Co Ltd | 低酸素応答誘導剤およびその製法 |
US7618940B2 (en) | 2002-12-06 | 2009-11-17 | Fibrogen, Inc. | Fat regulation |
-
2003
- 2003-12-04 US US10/729,167 patent/US7618940B2/en active Active
- 2003-12-05 CA CA2506159A patent/CA2506159C/en not_active Expired - Fee Related
- 2003-12-05 WO PCT/US2003/038690 patent/WO2004052285A2/en active Application Filing
- 2003-12-05 AU AU2003298926A patent/AU2003298926C1/en not_active Ceased
- 2003-12-05 EP EP03796688A patent/EP1578431A4/en not_active Withdrawn
- 2003-12-05 JP JP2005508474A patent/JP2006514113A/ja active Pending
-
2005
- 2005-05-02 IL IL168323A patent/IL168323A/en active IP Right Grant
- 2005-06-24 NO NO20053116A patent/NO20053116L/no not_active Application Discontinuation
-
2006
- 2006-07-10 HK HK06107698.4A patent/HK1087338A1/xx not_active IP Right Cessation
-
2009
- 2009-10-19 US US12/589,229 patent/US8202834B2/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
AU2003298926C1 (en) | 2010-02-04 |
WO2004052285A2 (en) | 2004-06-24 |
EP1578431A2 (en) | 2005-09-28 |
HK1087338A1 (en) | 2006-10-13 |
US20040235082A1 (en) | 2004-11-25 |
CA2506159A1 (en) | 2004-06-24 |
JP2006514113A (ja) | 2006-04-27 |
US7618940B2 (en) | 2009-11-17 |
IL168323A (en) | 2011-07-31 |
NO20053116L (no) | 2005-09-05 |
EP1578431A4 (en) | 2008-04-23 |
CA2506159C (en) | 2011-05-24 |
US8202834B2 (en) | 2012-06-19 |
AU2003298926A1 (en) | 2004-06-30 |
WO2004052285A3 (en) | 2004-09-02 |
AU2003298926B2 (en) | 2009-09-03 |
US20100168152A1 (en) | 2010-07-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20053116D0 (no) | Fettregulering. | |
NO20053248D0 (no) | Kerosenblanding. | |
NO20052248D0 (no) | Svivelstykkesystem. | |
NO20051500D0 (no) | Substituerte heterocyklylpyrimidiner. | |
NO20051497D0 (no) | Beta-laktamaseinhibitorprodrug. | |
DK1497496T3 (da) | Værdidokument | |
ITMI20032170A1 (it) | Tagliacimosse. | |
NO20033080D0 (no) | Reguleringssele | |
ES1052590Y (es) | Quiosco-consigna. | |
FIU20030034U0 (fi) | Asetuki | |
ES1052699Y (es) | Piragua desmontable. | |
ES1052029Y (es) | Balin-proyectil. | |
ES1052945Y (es) | Contraventana. | |
ES1052938Y (es) | Cantonera. | |
ES1052654Y (es) | Cubitera. | |
ES1052011Y (es) | Espetero. | |
ES1051703Y (es) | Potera. | |
ES1051605Y (es) | Cromo-puzzle. | |
ES1051110Y (es) | Caja-palet. | |
ITVE20020013U1 (it) | Bloccalaccio. | |
ITVI20020277A1 (it) | Salvapenne. | |
ITTO20020722A1 (it) | Alchinilcarbossi-nucleotidi. | |
ITTO20020864A1 (it) | Salvapolsino. | |
ITRM20020327A0 (it) | Dnaser. | |
NL1020250A1 (nl) | Stelwig. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |